Concepedia

Stefan Lundh

SL

Statistics

Publications

9

Citations

4.1K

H-Index

9

Active since

2018

Affiliations

University of Pennsylvania(Current)

Parker Institute for Cancer Immunotherapy

Children's Hospital of Philadelphia

Novartis (United States)

Philadelphia University

Stefan Lundh is an author at University of Pennsylvania specializing in life sciences, immunology, and cancer immunotherapy.

ORCID

Publications per year

2018–2023

9

Publications

9

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando et al. · Nature Medicine · 2018 · 1.8K citations · Full text

, , +16

Decade-long leukaemia remissions with persistence of CD4+ CAR T cells

J. Joseph Melenhorst, Gregory M. Chen, Meng Wang et al. · Nature · 2022 · 920 citations · Full text

, , +14

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons et al. · Nature · 2018 · 861 citations · Full text

, , +14

Reducing <i>Ex Vivo</i> Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells

Saba Ghassemi, Selene Nuñez-Cruz, Roddy S. O’Connor et al. · Cancer Immunology Research · 2018 · 302 citations · Full text

, , +15

Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL

Zhiliang Bai, Steven Woodhouse, Ziran Zhao et al. · Science Advances · 2022 · 161 citations · Full text

, , +17

1–5 of 9